BioAesthetics Corporation announced the appointment of Juliana Blum, PhD as its new Chief Executive Officer, effective August 12, 2024. Dr. Blum joins BioAesthetics with extensive experience in leading biotechnology organizations and will be instrumental in advancing the company's next gen drug-eluting graft technology for soft tissue reconstruction towards the clinic.